Biotron Limited
BITRF · OTC
6/30/2025 | 12/30/2024 | 6/30/2024 | 12/30/2023 | |
|---|---|---|---|---|
| Revenue | -$0 | $2 | $0 | $2 |
| % Growth | -100% | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $2 | -$0 | $2 |
| % Margin | 100% | 100% | – | 100% |
| R&D Expenses | $0 | $0 | $1 | $2 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $2 | $3 |
| Operating Income | -$1 | $1 | -$2 | -$1 |
| % Margin | 119,330% | 38.4% | – | -83.4% |
| Other Income/Exp. Net | $0 | -$0 | $0 | $0 |
| Pre-Tax Income | -$1 | $1 | -$2 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | $1 | -$2 | -$1 |
| % Margin | 116,958.5% | 38.4% | – | -80.5% |
| EPS | -0.001 | 0.001 | -0.002 | -0.001 |
| % Growth | -225% | 133.3% | -71.4% | – |
| EPS Diluted | -0.001 | 0.001 | -0.002 | -0.001 |
| Weighted Avg Shares Out | 1,096 | 998 | 903 | 903 |
| Weighted Avg Shares Out Dil | 1,096 | 992 | 902 | 902 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | $1 | -$2 | -$1 |
| % Margin | 118,854.1% | 38.8% | – | -82.1% |